SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-063675
Filing Date
2023-11-14
Accepted
2023-11-14 16:01:33
Documents
57
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q elym-20230930.htm   iXBRL 10-Q 2543752
2 EX-31.1 elym-ex31_1.htm EX-31.1 18687
3 EX-32.1 elym-ex32_1.htm EX-32.1 11236
  Complete submission text file 0000950170-23-063675.txt   8942903

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT elym-20230930_pre.xml EX-101.PRE 329982
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT elym-20230930_def.xml EX-101.DEF 182720
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT elym-20230930_lab.xml EX-101.LAB 441656
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT elym-20230930.xsd EX-101.SCH 56130
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT elym-20230930_cal.xml EX-101.CAL 31724
51 EXTRACTED XBRL INSTANCE DOCUMENT elym-20230930_htm.xml XML 1793912
Mailing Address 2801 CENTERVILLE ROAD 1ST FLOOR PMB #117 WILMINGTON DE 19808
Business Address 2801 CENTERVILLE ROAD 1ST FLOOR PMB #117 WILMINGTON DE 19808 877-354-3689
Eliem Therapeutics, Inc. (Filer) CIK: 0001768446 (see all company filings)

IRS No.: 832273741 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40708 | Film No.: 231405657
SIC: 2834 Pharmaceutical Preparations